ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $28,299,000 | +74.7% | 1,500,476 | +9.0% | 0.01% | +80.0% |
| Q2 2019 | $16,196,000 | -19.1% | 1,376,081 | -6.2% | 0.01% | -16.7% |
| Q1 2019 | $20,030,000 | +1565.0% | 1,467,405 | +1149.9% | 0.01% | – |
| Q4 2018 | $1,203,000 | -38.5% | 117,405 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $1,955,000 | +5.4% | 117,405 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,855,000 | +24.4% | 117,405 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,491,000 | +188.4% | 117,405 | +160.1% | 0.00% | – |
| Q4 2017 | $517,000 | -6.5% | 45,145 | 0.0% | 0.00% | – |
| Q3 2017 | $553,000 | -71.6% | 45,145 | -73.5% | 0.00% | -100.0% |
| Q2 2017 | $1,949,000 | -55.8% | 170,179 | -19.8% | 0.00% | -50.0% |
| Q1 2017 | $4,414,000 | -19.1% | 212,213 | -19.0% | 0.00% | 0.0% |
| Q4 2016 | $5,453,000 | -33.5% | 262,153 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $8,205,000 | +49.2% | 262,153 | +19.0% | 0.00% | +33.3% |
| Q2 2016 | $5,501,000 | -27.1% | 220,308 | -28.5% | 0.00% | -25.0% |
| Q1 2016 | $7,550,000 | -25.9% | 308,308 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $10,183,000 | +102.7% | 308,308 | +101.1% | 0.01% | +66.7% |
| Q3 2015 | $5,023,000 | – | 153,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |